Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer
Clinical trial NCT04405349 · COMPLETED
Trial details
- NCT number
- NCT04405349
- Sponsor
- Nykode Therapeutics ASA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2023-11-24
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.